NQ PE Project Stingray Parent, L.P.
Pharmaceutical company · Raleigh, North Carolina, United States
NQ PE Project Stingray Parent, L.P. is a pharmaceutical company headquartered in Raleigh, North Carolina, United States. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $11 million sold in a notice filed in 2022.
NQ PE Project Stingray Parent at a glance
What does NQ PE Project Stingray Parent do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $11.4 million sold (2022).
Frequently asked questions about NQ PE Project Stingray Parent
Where is NQ PE Project Stingray Parent headquartered?
NQ PE Project Stingray Parent, L.P. is headquartered in Raleigh, North Carolina, United States.
What does NQ PE Project Stingray Parent do?
NQ PE Project Stingray Parent, L.P. is a pharmaceutical company.
When was NQ PE Project Stingray Parent founded?
The earliest incorporation on record for NQ PE Project Stingray Parent, L.P. is in 2020, according to public company registers.
Similar companies
- 9 Meters Biopharma, Inc.Raleigh, North Carolina, United States
- Vogenx, Inc.Raleigh, North Carolina, United States
- Agile Sciences, IncRaleigh, North Carolina, United States
- Flag Therapeutics, Inc.Raleigh, North Carolina, United States
- Valanbio Therapeutics, Inc.Raleigh, North Carolina, United States
- Midatech Pharma US Inc.Raleigh, North Carolina, United States
- Biodelivery Sciences International IncRaleigh, North Carolina, United States
- Marius Pharmaceuticals, LLCRaleigh, North Carolina, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences